Table 2. Characteristics of the 41 enrolled patients.
Characteristic | Schedule A | Schedule B | Total |
---|---|---|---|
Number of patients | 19 | 22 | 41 |
Age, years | |||
Median | 54 | 54 | 54 |
Range | 35–76 | 25–81 | 25–81 |
Sex | |||
Male | 10 (53%) | 13 (59%) | 23 (56%) |
Female | 9 (47%) | 9 (41%) | 18 (44%) |
Ethnic origin | |||
White | 19 (100%) | 21 (96%) | 40 (98%) |
Black | 0 | 1 (4%) | 1 (2%) |
ECOG performance status | |||
0 | 6 (32%) | 8 (36%) | 14 (34%) |
1 | 11 (58%) | 14 (64%) | 25 (61%) |
2 | 1 (5%) | 0 | 1 (2%) |
Unknown | 1 (5%) | 0 | 1 (2%) |
Histopathology | |||
Melanoma | 14 (74%) | 22 (100%) | 36 (87%) |
Adenocarcinoma, NOS | 3 (16%) | 0 | 3 (7%) |
Mucinous adenocarcinoma | 1 (5%) | 0 | 1 (2%) |
Small-cell carcinoma, NOS | 1 (5%) | 0 | 1 (2%) |
Previous therapy | |||
Chemotherapy | 7 (37%) | 4 (18%) | 11 (27%) |
Immunotherapy | 10 (53%) | 13 (59%) | 23 (56%) |
Radiation | 4 (21%) | 4 (18%) | 8 (20%) |
Other | 4 (21%) | 1 (4%) | 5 (12%) |
Abbreviations: ECOG=Eastern Cooperative Oncology Group; NOS=not otherwise specified.